NeuroScientific Biopharmaceuticals Limited (NSB.AX)
AUD 0.04
(0.0%)
AUD 0.04
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | -4.95 Million AUD | -0.86% |
| 2023 | -4.91 Million AUD | 31.93% |
| 2022 | -7.21 Million AUD | 49.05% |
| 2021 | -14.16 Million AUD | -330.88% |
| 2020 | -3.28 Million AUD | 28.7% |
| 2019 | -4.6 Million AUD | -4336.85% |
| 2018 | -103.89 Thousand AUD | 17.42% |
| 2017 | -125.8 Thousand AUD | -2529.17% |
| 2016 | -4785.00 AUD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q4 | -4.95 Million AUD | 0.0% |
| 2024 Q2 | -3.33 Million AUD | 0.0% |
| 2024 FY | -4.95 Million AUD | -0.86% |
| 2023 Q4 | -4.91 Million AUD | 0.0% |
| 2023 Q2 | -3.32 Million AUD | 0.0% |
| 2023 FY | -4.91 Million AUD | 31.93% |
| 2022 Q2 | -9.49 Million AUD | 0.0% |
| 2022 FY | -7.21 Million AUD | 49.05% |
| 2022 Q4 | -7.21 Million AUD | 0.0% |
| 2021 FY | -14.16 Million AUD | -330.88% |
| 2021 Q2 | -4.98 Million AUD | 0.0% |
| 2021 Q4 | -14.16 Million AUD | 0.0% |
| 2020 Q2 | -4.17 Million AUD | 0.0% |
| 2020 Q4 | -3.28 Million AUD | 0.0% |
| 2020 FY | -3.28 Million AUD | 28.7% |
| 2019 FY | -4.6 Million AUD | -4336.85% |
| 2019 Q2 | -5.08 Million AUD | 0.0% |
| 2019 Q4 | -4.6 Million AUD | 0.0% |
| 2018 FY | -103.89 Thousand AUD | 17.42% |
| 2018 Q4 | -103.89 Thousand AUD | 0.0% |
| 2018 Q2 | 6958.00 AUD | 0.0% |
| 2017 Q4 | -125.8 Thousand AUD | 0.0% |
| 2017 FY | -125.8 Thousand AUD | -2529.17% |
| 2016 FY | -4785.00 AUD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AdAlta Limited | -845.17 Thousand AUD | -486.169% |
| Acrux Limited | -1.45 Million AUD | -239.79% |
| Race Oncology Limited | -17.18 Million AUD | 71.178% |
| Biome Australia Limited | -1.56 Million AUD | -217.003% |
| Botanix Pharmaceuticals Limited | -79.3 Million AUD | 93.753% |
| BTC Health Limited | -2.02 Million AUD | -144.993% |
| Chimeric Therapeutics Limited | -3.05 Million AUD | -62.271% |
| CSL Limited | 15.76 Billion AUD | 100.031% |
| Clarity Pharmaceuticals Ltd | -136.5 Million AUD | 96.371% |
| Clinuvel Pharmaceuticals Limited | -182.98 Million AUD | 97.293% |
| EZZ Life Science Holdings Limited | -18.89 Million AUD | 73.786% |
| Hexima Limited | -2.22 Million AUD | -122.537% |
| Immutep Limited | -122.18 Million AUD | 95.946% |
| Memphasys Limited | 4.13 Million AUD | 219.799% |
| Neuren Pharmaceuticals Limited | -17.09 Million AUD | 71.018% |
| Noxopharm Limited | -2.31 Million AUD | -113.547% |
| Prescient Therapeutics Limited | -10.16 Million AUD | 51.252% |
| Radiopharm Theranostics Limited | -18.57 Million AUD | 73.329% |
| Starpharma Holdings Limited | -19.83 Million AUD | 75.019% |
| Tissue Repair Ltd | -16.44 Million AUD | 69.867% |
| Biotron Limited | -386.06 Thousand AUD | -1183.23% |
| Alterity Therapeutics Limited | -12.47 Million AUD | 60.303% |
| Anatara Lifesciences Ltd | -982.1 Thousand AUD | -404.44% |
| Bio-Gene Technology Limited | -709.55 Thousand AUD | -598.201% |
| Zelira Therapeutics Limited | 5.06 Million AUD | 197.766% |
| Patrys Limited | -2.24 Million AUD | -121.102% |
| Orthocell Limited | -19.92 Million AUD | 75.136% |
| Imugene Limited | -91.56 Million AUD | 94.589% |
| PYC Therapeutics Limited | -65.76 Million AUD | 92.467% |
| Proteomics International Laboratories Limited | -6.32 Million AUD | 21.659% |
| Cynata Therapeutics Limited | -6.2 Million AUD | 20.164% |
| Arovella Therapeutics Limited | -12.71 Million AUD | 61.035% |
| Nanollose Limited | -96.22 Thousand AUD | -5048.498% |
| Invex Therapeutics Ltd | -6.02 Million AUD | 17.775% |
| Amplia Therapeutics Limited | -1.82 Million AUD | -171.67% |
| Island Pharmaceuticals Limited | -1.23 Million AUD | -300.041% |
| Nyrada Inc. | -4.76 Million AUD | -3.874% |
| Telix Pharmaceuticals Limited | -105.79 Million AUD | 95.317% |
| Dimerix Limited | -21.99 Million AUD | 77.473% |
| PharmAust Limited | -9.71 Million AUD | 49.001% |
| AnteoTech Limited | -5 Million AUD | 0.947% |
| Paradigm Biopharmaceuticals Limited | -17.58 Million AUD | 71.822% |
| Recce Pharmaceuticals Ltd | -3.39 Million AUD | -45.876% |
| Avecho Biotechnology Limited | -5.32 Million AUD | 7.039% |
| Actinogen Medical Limited | -9.13 Million AUD | 45.748% |
| Immuron Limited | -11.48 Million AUD | 56.86% |
| Argenica Therapeutics Limited | -15.91 Million AUD | 68.867% |